Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01307891. IPD Sharing: NO. Countries: 1. Publications: 1.
Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT02574455. IPD Sharing: YES. Countries: 7. Publications: 9.
Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01167192. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03639948. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02981303. IPD Sharing: NO. Countries: 1. Publications: 2.
Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT02120469. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
ClinicalTrials.gov study NCT01920061. IPD Sharing: NO. Countries: 5. Publications: 1.
Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT00542191. IPD Sharing: Not stated. Countries: 1. Publications: 17.
Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02779855. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
ClinicalTrials.gov study NCT02425891. IPD Sharing: Not stated. Countries: 40. Publications: 5.
Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adj
ClinicalTrials.gov study NCT02688803. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
BKM120 For Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01790932. IPD Sharing: NO. Countries: 1. Publications: 1.
Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03206203. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT01116648. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03742102. IPD Sharing: YES. Countries: 6. Publications: 0.
A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01629615. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours
ClinicalTrials.gov study NCT03620643. IPD Sharing: NO. Countries: 1. Publications: 17.
ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03733119. IPD Sharing: NO. Countries: 1. Publications: 1.
A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00789581. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02547987. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.